Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
St. Jude Medical Reports First Quarter 2016 Results
April 20, 2016 7:15 AM EDTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today reported sales and net earnings for the first quarter ended April 2, 2016.
First quarter 2016 highlights:
Net sales of $1.448 billion increased 8 percent as reported, or 2 percent on a comparable constant currency basis, at the high end of the companys guidance range. St. Jude Medical has successfully completed its integration of Thoratec; left ventricular assist device (LVAD) sales grew strong double digits on a comparable constant currency basis.... MoreSt. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark
April 19, 2016 8:02 AM EDTProminent European electrophysiology labs and hospitals have embraced the next generation mapping systems automation, flexibility and precision for tailoring treatment for patients with cardiac arrhythmias
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe and use of the new platform in more than 600 cases in nine countries since receiving CE Mark in January 2016. The mapping system is a next-generation platform designed to provide automation, flexibility and precision for tailored... More
St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology
April 18, 2016 8:00 AM EDTThe St. Jude Medical MultiPoint Pacing technology advances options for clinicians to tailor therapy for heart failure patients
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, recently received U.S. Food and Drug Administration (FDA) approval of the companys proprietary, first-to-market... More
